$CDAQF
Compass Digital Acquisition Corp. Stock $cdaqf

$cdaqf Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224045998 Filed on November 14, 2024

Income Statement

Concept	2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit	-$4.944M
YoY Change	731.04%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$4.568M
YoY Change	-327.37%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$33.54K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses	$23.63K
Receivables
Other Receivables
Total Short-Term Assets	$57.18K
YoY Change	-89.34%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$27.37M
YoY Change	-87.74%
TOTAL ASSETS
Total Short-Term Assets	$57.18K
Total Long-Term Assets	$27.37M
Total Assets	$27.43M
YoY Change	-87.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$550.9K
YoY Change	82.71%
Accrued Expenses	$557.7K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.537M
YoY Change	497.63%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.537M
Total Long-Term Liabilities
Total Liabilities	$6.264M
YoY Change	76.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.207M
YoY Change	105.96%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.207M
YoY Change
Total Liabilities & Shareholders Equity	$27.43M
YoY Change	-87.74%

Cashflow Statement

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	-$4.568M
YoY Change	-327.37%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	CDAQ	Gain On Settlement Of Professional Legal Fees GainOnSettlementOfProfessionalLegalFees		usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001851909
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Entity File Number EntityFileNumber	001-40912
	dei	Entity Registrant Name EntityRegistrantName	Compass Digital Acquisition Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Address Address Line1 EntityAddressAddressLine1	195 US HWY 50
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 309
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89448
	dei	City Area Code CityAreaCode	(775)
	dei	Local Phone Number LocalPhoneNumber	339-1671
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	57177	usd
CY2024Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	27369390	usd
CY2024Q3	us-gaap	Assets Assets	27426567	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	550873	usd
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	CDAQ	Nonredemption Liability NonredemptionLiability		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	CDAQ	Nonredemption Expense NonredemptionExpense		usd
	CDAQ	Nonredemption Expense NonredemptionExpense		usd
CY2024Q3	CDAQ	Gain On Settlement Of Deferred Underwriting Fees Attributable To Public Warrants GainOnSettlementOfDeferredUnderwritingFeesAttributableToPublicWarrants		usd
	CDAQ	Gain On Settlement Of Deferred Underwriting Fees Attributable To Public Warrants GainOnSettlementOfDeferredUnderwritingFeesAttributableToPublicWarrants		usd
	CDAQ	Gain On Settlement Of Professional Legal Fees GainOnSettlementOfProfessionalLegalFees		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	CDAQ	Gain On Settlement Of Deferred Underwriting Fees Attributable To Public Warrants GainOnSettlementOfDeferredUnderwritingFeesAttributableToPublicWarrants		usd
	CDAQ	Gain On Settlement Of Professional Legal Fees GainOnSettlementOfProfessionalLegalFees		usd
	CDAQ	Nonredemption Expense NonredemptionExpense		usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	CDAQ	Redemption Of Ordinary Shares Subject To Possible Redemption RedemptionOfOrdinarySharesSubjectToPossibleRedemption		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	CDAQ	Proceeds From Capital Contribution From Sponsor ProceedsFromCapitalContributionFromSponsor		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	CDAQ	Return Of Excess Contribution Capital To Legacy Sponsor ReturnOfExcessContributionCapitalToLegacySponsor		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	CDAQ	Allocation Of Polar Capital Investment Payable Proceeds To Equity Instrument AllocationOfPolarCapitalInvestmentPayableProceedsToEquityInstrument		usd
	CDAQ	Deferred Underwriting Fees Waiver DeferredUnderwritingFeesWaiver		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	dei	Entity Address City Or Town EntityAddressCityOrTown	Zephyr Cove
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q3	us-gaap	Cash Cash	33544	usd
CY2023Q4	us-gaap	Cash Cash	44046	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	23633	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	35635	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	79681	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	55347556	usd
CY2023Q4	us-gaap	Assets Assets	55427237	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	476567	usd
CY2024Q3	CDAQ	Nonredemption Liability NonredemptionLiability	4076270	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	125000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	125000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	557671	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	167798	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5537087	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	860274	usd
CY2024Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	726646	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	588464	usd
CY2024Q3	us-gaap	Liabilities Liabilities	6263733	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1448738	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6207087	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1369588	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6206556	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1369057	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27426567	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55427237	usd
CY2024Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	837885	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	564934	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1561687	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1176968	usd
CY2024Q3	CDAQ	Nonredemption Expense NonredemptionExpense	4076270	usd
	CDAQ	Nonredemption Expense NonredemptionExpense	4076270	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	90000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4944155	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-594934	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5727957	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1246968	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	13103	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	850533	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	138182	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1670094	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	389048	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2856382	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1660199	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7729397	usd
CY2023Q3	CDAQ	Gain On Settlement Of Deferred Underwriting Fees Attributable To Public Warrants GainOnSettlementOfDeferredUnderwritingFeesAttributableToPublicWarrants	246814	usd
	CDAQ	Gain On Settlement Of Deferred Underwriting Fees Attributable To Public Warrants GainOnSettlementOfDeferredUnderwritingFeesAttributableToPublicWarrants	246814	usd
CY2023Q3	CDAQ	Gain On Settlement Of Professional Legal Fees GainOnSettlementOfProfessionalLegalFees	351409	usd
	CDAQ	Gain On Settlement Of Professional Legal Fees GainOnSettlementOfProfessionalLegalFees	351409	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-4568210	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	2009138	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4205940	usd
	us-gaap	Net Income Loss NetIncomeLoss	5410558	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1369057	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	204549	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	631967	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-113190	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1909665	usd
CY2024Q2	CDAQ	Adjustments To Additional Paid In Capital Capital Contribution From Sponsor AdjustmentsToAdditionalPaidInCapitalCapitalContributionFromSponsor	295000	usd
CY2024Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	639184	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	475460	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-1778389	usd
CY2024Q3	CDAQ	Adjustments To Additional Paid In Capital Capital Contribution From Sponsor AdjustmentsToAdditionalPaidInCapitalCapitalContributionFromSponsor	120000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	409091	usd
CY2024Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	389048	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-4568210	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-6206556	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8355583	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2304389	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1389974	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-9269998	usd
CY2023Q2	CDAQ	Remeasurement Of Ordinary Shares To Redemption Value RemeasurementOfOrdinarySharesToRedemptionValue	2568625	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2011446	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-9827177	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-9827177	usd
CY2023Q3	CDAQ	Gain On Settlement Of Deferred Underwriting Fees GainOnSettlementOfDeferredUnderwritingFees	7187357	usd
CY2023Q3	CDAQ	Stock Issued During Period Value Return Of Excess Contribution Capital To Legacy Sponsor StockIssuedDuringPeriodValueReturnOfExcessContributionCapitalToLegacySponsor	-49093	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	523000	usd
CY2023Q3	CDAQ	Remeasurement Of Ordinary Shares To Redemption Value RemeasurementOfOrdinarySharesToRedemptionValue	2856383	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	2009138	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	2009138	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3013158	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3013158	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4205940	usd
	us-gaap	Net Income Loss NetIncomeLoss	5410558	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1660199	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7729397	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	138182	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1670094	usd
	CDAQ	Gain On Settlement Of Deferred Underwriting Fees Attributable To Public Warrants GainOnSettlementOfDeferredUnderwritingFeesAttributableToPublicWarrants	246814	usd
	CDAQ	Gain On Settlement Of Professional Legal Fees GainOnSettlementOfProfessionalLegalFees	351409	usd
	CDAQ	Nonredemption Expense NonredemptionExpense	4076270	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-12006	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-255528	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	464179	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	222400	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1175502	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-769040	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	29638365	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29638365	usd
	CDAQ	Redemption Of Ordinary Shares Subject To Possible Redemption RedemptionOfOrdinarySharesSubjectToPossibleRedemption	29638365	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	750000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	35000	usd
	CDAQ	Proceeds From Capital Contribution From Sponsor ProceedsFromCapitalContributionFromSponsor	415000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	177500	usd
	CDAQ	Return Of Excess Contribution Capital To Legacy Sponsor ReturnOfExcessContributionCapitalToLegacySponsor	49093	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	24821	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28473365	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	283586	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10502	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-485454	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44046	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	936434	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33544	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	450980	usd
	CDAQ	Allocation Of Polar Capital Investment Payable Proceeds To Equity Instrument AllocationOfPolarCapitalInvestmentPayableProceedsToEquityInstrument	-908636	usd
	CDAQ	Deferred Underwriting Fees Waiver DeferredUnderwritingFeesWaiver	-7187357	usd
	us-gaap	Stock Issued1 StockIssued1	523000	usd
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	200000000	usd
	CDAQ	Purchased An Aggregate PurchasedAnAggregate	20000000	shares
	CDAQ	Offering Price OfferingPrice	10.00
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	200000000	usd
	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	199999	usd
	CDAQ	Allocation Of Offering Costs And Founders Shares To Warrant Expense AllocationOfOfferingCostsAndFoundersSharesToWarrantExpense	631124	usd
	CDAQ	Fair Value In Excess Of Consideration FairValueInExcessOfConsideration	10414655	usd
CY2021Q4	CDAQ	Net Proceeds NetProceeds	200000000	usd
CY2021Q4	CDAQ	Price Per Share PricePerShare	10.00
CY2021Q4	CDAQ	Maturity Days MaturityDays	P185D
CY2021Q4	CDAQ	Private Placement Warrants PrivatePlacementWarrants	165398	shares
CY2021Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	248097	usd
CY2024Q3	us-gaap	General Fair Value Hedge Information Minimum R Square Percentage GeneralFairValueHedgeInformationMinimumRSquarePercentage	0.80	pure
	CDAQ	Percentage Of Outstanding Voting Securities PercentageOfOutstandingVotingSecurities	0.50	pure
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	5000001	usd
	CDAQ	Aggregate Share Percentage AggregateSharePercentage	0.15	pure
	CDAQ	Dissolution Expenses DissolutionExpenses	50000	usd
CY2024Q3	us-gaap	Share Price SharePrice	10.00
	CDAQ	Value Of The Trust Assets ValueOfTheTrustAssets	10.00
CY2024Q3	us-gaap	Cash Cash	33544	usd
CY2024Q3	CDAQ	Working Capital Deficit WorkingCapitalDeficit	-5479910	usd
CY2024Q3	CDAQ	Cash Payments CashPayments	25000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	125000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zVp4d7TFGanf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Cash Cash	33544	usd
CY2023Q4	us-gaap	Cash Cash	44046	usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q3	CDAQ	Cash Held In The Trust Account CashHeldInTheTrustAccount	27369390	usd
CY2023Q4	CDAQ	Cash Held In The Trust Account CashHeldInTheTrustAccount	55347556	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zQ3M74PVDB2h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20240930_zDRzMnWaA43l" title="FDIC insured amount">250,000</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMPASS DIGITAL ACQUISITION CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEPTEMBER 30, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Shares Issued SharesIssued	20000000	shares
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	10.00
CY2021Q4	CDAQ	Gross Proceeds GrossProceeds	200000000	usd
CY2021Q4	CDAQ	Incurring Offering Costs IncurringOfferingCosts	11929189	usd
CY2021Q4	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	4000000	usd
CY2021Q4	CDAQ	Deferred Underwriting Fees DeferredUnderwritingFees	7000000	usd
CY2021Q4	CDAQ	Other Offering Costs OtherOfferingCosts	929189	usd
CY2021Q4	CDAQ	Shares Issued1 SharesIssued1	20000000	shares
CY2021Q4	CDAQ	Public Offering Price Per Share PublicOfferingPricePerShare	10.00
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1240488	shares
CY2021Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	248097	usd
	CDAQ	Sponsor Purchased SponsorPurchased	4666667	shares
CY2024Q3	CDAQ	Price Per Warrant PricePerWarrant	1.50
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	7000000	usd
	CDAQ	Aggregate Of Private Placement Warrants AggregateOfPrivatePlacementWarrants	186667	shares
CY2021Q1	us-gaap	Shares Issued SharesIssued	5750000	shares
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	25000	usd
	CDAQ	Founder Shares Subject To Forfeiture FounderSharesSubjectToForfeiture	750000	shares
	CDAQ	Companys Issued And Outstanding Percentage CompanysIssuedAndOutstandingPercentage	0.20	pure
CY2024Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.004
CY2024Q3	CDAQ	Proceeds From Capital Contribution From Sponsor ProceedsFromCapitalContributionFromSponsor	120000	usd
	CDAQ	Proceeds From Capital Contribution From Sponsor ProceedsFromCapitalContributionFromSponsor	415000	usd
CY2024Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.50
CY2021	CDAQ	Issued Of Unsecured Promissory Note IssuedOfUnsecuredPromissoryNote	1000000	usd
CY2024Q3	CDAQ	Withdrawn Of Outstanding Working Capital Loans WithdrawnOfOutstandingWorkingCapitalLoans	125000	usd
CY2023Q4	CDAQ	Withdrawn Of Outstanding Working Capital Loans WithdrawnOfOutstandingWorkingCapitalLoans	125000	usd
CY2023Q3	CDAQ	Working Capital Loans WorkingCapitalLoans	1500000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	10000	usd
CY2024Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	30000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	90000	usd
CY2023Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	30000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	70000	usd
	CDAQ	Underwriters Shares Additional Units UnderwritersSharesAdditionalUnits	3000000	shares
CY2024Q3	CDAQ	Deferred Underwriting Fee DeferredUnderwritingFee	7434171	usd
CY2024Q3	CDAQ	Accumulated Deficit AccumulatedDeficit	7187357	usd
CY2024Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	6666667	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4666667	shares
	CDAQ	Warrants Expire Date WarrantsExpireDate	P5Y
	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.60	pure
CY2024Q3	us-gaap	Preferred Units Authorized PreferredUnitsAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Units Authorized PreferredUnitsAuthorized	1000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Units Issued PreferredUnitsIssued	0	shares
CY2024Q3	us-gaap	Preferred Units Outstanding PreferredUnitsOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Units Issued PreferredUnitsIssued	0	shares
CY2023Q4	us-gaap	Preferred Units Outstanding PreferredUnitsOutstanding	0	shares
	CDAQ	Companys Issued And Outstanding Percentage CompanysIssuedAndOutstandingPercentage	0.20	pure
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
cdaq-20240930_cal.xml	Edgar Link	unprocessable
0001493152-24-045998-index-headers.html	Edgar Link	pending
0001493152-24-045998-index.html	Edgar Link	pending
0001493152-24-045998.txt	Edgar Link	pending
0001493152-24-045998-xbrl.zip	Edgar Link	pending
cdaq-20240930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
cdaq-20240930_def.xml	Edgar Link	unprocessable
cdaq-20240930_lab.xml	Edgar Link	unprocessable
cdaq-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDAQF
Compass Digital Acquisition Corp. Stock $cdaqf

2024 Q3 Form 10-Q Financial Statement

#000149315224045998 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDAQF Compass Digital Acquisition Corp. Stock $cdaqf

2024 Q3 Form 10-Q Financial Statement

#000149315224045998 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDAQF
Compass Digital Acquisition Corp. Stock $cdaqf